Ingredient or product comparison
GHK-Cu Arthritis Research — Comparison of Mechanisms
Cytokine Suppression Downregulates IL-6, IL-1, TNF- via NF- B inhibition No direct effect on cytokine transcription Broad immunosuppression via glucocorticoid receptor GHK-Cu selectively targets inflammatory pathways without immune suppression MMP Inhibition
This source-based comparison does not add ratings or recommend a winner.
- Cytokine Suppression
- Downregulates IL-6, IL-1β, TNF-α via NF-κB inhibition
- No direct effect on cytokine transcription
- Broad immunosuppression via glucocorticoid receptor
- GHK-Cu selectively targets inflammatory pathways without immune suppression
- MMP Inhibition
- Upregulates TIMP-1/TIMP-2, reducing MMP-1, MMP-3, MMP-13 activity
- No effect on metalloproteinases
- Transient MMP reduction, long-term cartilage thinning risk
- GHK-Cu rebalances MMP/TIMP ratio; corticosteroids worsen matrix over time
- Collagen Synthesis
- Enhances TGF-β1 signaling, supporting collagen I/III deposition
- No anabolic effect
- Inhibits collagen synthesis
- GHK-Cu is the only intervention that promotes tissue repair while reducing inflammation
- Oxidative Stress
- Increases SOD activity, reducing ROS-driven NF-κB activation
- No antioxidant effect
- Copper-bound peptide uniquely addresses oxidative component of arthritis
- Mechanism Onset
- Transcriptional changes occur within 24–72 hours in vitro
- Prostaglandin inhibition within 30–60 minutes
- Genomic effects within 4–6 hours
- GHK-Cu onset is slower but addresses root inflammatory signaling